We have previously reported that the PKC GEMM, with the activated mutant Kras allele and inactivated p16 locus, can develop a full spectrum of PanIN lesions, which progress to invasive cancer and metastasis, mimicking human pancreatic tumorigenesis at both genetic and histologic levels (22). This evidence concerns the gene CDKN2A and cancer.